What Are TPO Antibodies?
TPO (thyroid peroxidase) antibodies are autoantibodies directed against thyroid peroxidase, an enzyme critical for thyroid hormone synthesis, and they serve as the most sensitive marker for autoimmune thyroid disease, particularly Hashimoto's thyroiditis. 1
Definition and Biological Basis
TPO antibodies are IgG-class autoantibodies that target thyroid peroxidase, a key enzyme located in thyroid follicular cells that catalyzes iodination of thyroglobulin during thyroid hormone production. 2 These antibodies were historically identified as "anti-microsomal antibodies" before the specific antigen (TPO) was characterized. 3
- TPO antibodies recognize conformationally intact TPO protein, specifically targeting an immunodominant region comprising overlapping A and B domains on the enzyme. 2
- The antibodies bind to regions with homology to myeloperoxidase and complement control protein domains of the TPO molecule. 2
Clinical Significance and Diagnostic Value
TPO antibodies are the most sensitive marker among all thyroid autoantibodies for diagnosing autoimmune thyroid disease. 1
Prevalence in Thyroid Disorders:
- 85-90% of patients with Hashimoto's thyroiditis (chronic autoimmune hypothyroidism) have positive TPO antibodies 1
- 53-70% of patients with Graves' disease test positive 4, 5
- High correlation exists between TPO antibody titers and the degree of lymphocytic infiltration in the thyroid gland 5
Prognostic Value:
- TPO antibody presence predicts progression to overt hypothyroidism: 4.3% per year in antibody-positive individuals versus 2.6% per year in antibody-negative individuals 6
- Women with positive TPO antibodies have increased risk of postpartum thyroiditis 5
- Detectable TPO antibodies (>5 kU/L) are associated with increased overall mortality (HR 1.09), cancer-related mortality (HR 1.18), and cardiovascular mortality (HR 1.21), particularly in men 7
Measurement and Interpretation
Modern assays use recombinant human TPO protein to measure antibodies specifically and sensitively. 1
- Positive threshold: typically >35 kU/L or >200-500 units/mL depending on assay 4, 7
- Specificity of 100% for autoimmune thyroid disease when using appropriate cutoffs 4
- TPO antibody assays have superior specificity compared to older microsomal antibody tests, avoiding false-positives in patients with high anti-thyroglobulin antibodies or non-thyroidal illness 4
Clinical Limitations
Despite their diagnostic utility, TPO antibodies have important limitations in clinical decision-making:
- Antibody presence or absence does not change the diagnosis of subclinical hypothyroidism (which is based on TSH measurements) or the expected efficacy of treatment 6
- Evidence is insufficient to recommend routine TPO antibody measurement in patients with subclinical hypothyroidism, as their presence doesn't alter management decisions 6
- TPO antibody levels may decrease by >50% during treatment of hyperthyroidism after achieving euthyroid state, but changes during hypothyroidism treatment are variable and inconsistent 4
Key Determinants
Female sex (OR 2.47) and current smoking (OR 3.10) are the strongest determinants associated with TPO antibody positivity, while alcohol consumption is associated with lower odds of detectable antibodies 7